argus

Aurobindo Pharma Ltd.

NSE: AUROPHARMAINE406A01037₹96,836 Cr

Timeline

Time (IST)TypeMEventSrc
26 Sept, 05:30 pm—…Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Updates on Acquisitionbse
26 Sept, 05:29 pm—…Aurobindo Pharma Limited has updated the Exchange about transfer of shares among subsidiary companiesnse
26 Sept, 03:54 pm—…Aurobindo Pharma Ltd - 524804 - Announcement under Regulation 30 (LODR)-Updates on Acquisitionbse
26 Sept, 03:51 pm—…Aurobindo Pharma Limited has updated on acquisition of 26% stake in Swarnaakshu Solar Power Private Limitednse
19 Sept, 01:21 pm—…Aurobindo Pharma Limited has informed the Exchange about fire accident at Unit-IV of APL Healthcare Limited, a WOS of the Companynse
19 Sept, 10:16 am—…Aurobindo Pharma Limited has informed the Exchange about completion Phase 3 Clinical Study for Denosumab Biosimilar vy CuaTeQ Biologicsnse
17 Sept, 05:24 pm—…Aurobindo Pharma Ltd - 524804 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.bse
17 Sept, 05:18 pm—…Aurobindo Pharma Limited has informed the Exchange about incorporation of Aurobindo Pharma (Malaysia) SDN. BHD. in Malaysianse
12 Sept, 02:35 pm—…Aurobindo Pharma Limited has informed the Exchange about General Updatesnse
12 Sept, 02:25 pm—…Aurobindo Pharma Ltd - 524804 - Clarification On Significant Volume Movement In Company'S Sharesbse
12 Sept, 01:21 pm—…Aurobindo Pharma Ltd - 524804 - Clarification sought from Aurobindo Pharma Ltdbse
05 Sept, 06:36 pm—…Aurobindo Pharma Limited has informed the Exchange about completion of US FDA Audit at its Unit XIInse